Scientists probe immune system in severe COVID-19 to find new clues
NCT ID NCT04392401
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study follows 200 adults with COVID-19 in intensive care to see how their immune systems change over time. Researchers will collect blood samples at several points during the hospital stay and track health outcomes. The goal is to understand why some patients get worse and to find new ways to treat or prevent severe illness.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify new treatments and biological markers to better manage COVID-19 in intensive care.
- What could go wrong
- This is an observational study, not testing a treatment. It may not directly lead to new therapies, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTENSIVE CARE UNIT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH de St Etienne
NOT_YET_RECRUITINGSaint-Etienne, 42055, France
-
Centre hospitalier universitaire de Grenoble Alpes
NOT_YET_RECRUITINGGrenoble, 38043, France
-
Hôpial de la Croix Rousse
RECRUITINGLyon, 69004, France
-
Hôpital Edouard Herriot
RECRUITINGLyon, 69003, France
-
Hôpital Edouard Herriot
RECRUITINGLyon, 69003, France
-
Hôpital Gabriel Montpied
NOT_YET_RECRUITINGClermont-Ferrand, 63000, France
-
Hôpital Lyon Sud
RECRUITINGPierre-Bénite, 69310, France
-
Hôpital Pierre Wertheimer
RECRUITINGBron, 69500, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict superbug evolution in the ICU?
- Can a new pill keep High-Risk COVID-19 patients out of the hospital?
- Could a five-day pill course cut COVID-19 deaths? czech nationwide data puts molnupiravir to the test.
- Millions of vaccine records scoured for rare side effects
- Could albumin boost oxygen delivery in sepsis? new trial investigates
- Life after a seizure emergency: study tracks hidden toll on mind and body